Although, we further demonstrated that ANGPTL8 expression gradually increases as NAFLD progresses and is highest in patients with HCC [13], whether ANGPTL8 plays a role in hepatocarcinogenesis is unclear. The gene discussed is ANGPTL8; the disease is metabolic dysfunction-associated steatotic liver disease.